Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging

Naranjan S Dhalla1, Shashanka Rangi, Andrea P Babick

  • 1Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, 351 Tache Avenue, Winnipeg, MB, Canada. nsdhalla@sbrc.ca

Heart Failure Reviews
|August 19, 2011
PubMed

Insights

Aging and myocardial infarction accelerate heart failure by causing cardiac remodeling and defects in subcellular organelles. These changes lead to calcium overload and impaired heart function in elderly individuals.

Area of Science:

  • Cardiovascular Biology
  • Cellular Physiology
  • Gerontology

Background:

  • Elderly individuals are highly susceptible to myocardial infarction and subsequent heart failure.
  • Known risk factors for heart failure include hypertension, cardiac hypertrophy, coronary artery disease, and diabetes.

Purpose of the Study:

  • To discuss cardiac dysfunction in hearts failing due to myocardial infarction and aging.
  • To highlight the association between cardiac remodeling, subcellular organelle defects, and heart failure.

Main Methods:

  • Review of evidence linking subcellular remodeling to intracellular Ca(2+)-overload and cardiac dysfunction.
  • Analysis of alterations in gene expression for sarcolemma (SL), sarcoplasmic reticulum (SR), and myofibrillar proteins.
  • Examination of defective phosphorylation mechanisms regulating Ca(2+)-handling and binding proteins.

Main Results:

  • Subcellular remodeling is critical for Ca(2+)-overload and cardiac dysfunction in myocardial infarction and aging-related heart failure.
  • Altered gene expression in SL and SR proteins causes Ca(2+)-handling abnormalities in cardiomyocytes.
  • Defects in myofibrillar proteins impair Ca(2+) interaction, contributing to cardiac dysfunction.

Conclusions:

  • Subcellular remodeling, particularly defects in Ca(2+)-handling and binding proteins, is intimately linked to cardiac remodeling and heart failure.
  • Dysfunctional Ca(2+) regulation in cardiomyocytes is a key mechanism in heart failure.
  • Targeting subcellular organelle function may offer therapeutic strategies for heart failure.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...